MARKET

TLX

TLX

Telix Pharmaceuticals Ltd ADR
NASDAQ
16.23
+0.09
+0.56%
After Hours: 16.19 -0.04 -0.25% 16:52 07/18 EDT
OPEN
16.43
PREV CLOSE
16.14
HIGH
16.43
LOW
15.80
VOLUME
13.13K
TURNOVER
--
52 WEEK HIGH
30.36
52 WEEK LOW
13.61
MARKET CAP
5.43B
P/E (TTM)
180.53
1D
5D
1M
3M
1Y
5Y
1D
Telix Pharmaceuticals Ltd. Receives Regulatory Approval for Illuccix® PSMA-PET Imaging Agent in Austria for Prostate Cancer Detection
Reuters · 1d ago
BUZZ-Australian healthcare stocks fall after Trump gives details on pharma tariffs
Reuters · 3d ago
Weekly Report: what happened at TLX last week (0707-0711)?
Weekly Report · 4d ago
BUZZ-Australia's Telix Pharmaceuticals rises on US code approval for imaging agent
Reuters · 07/09 03:00
Telix Pharmaceuticals Announces Lapse of Share Rights, Reducing Issued Capital by Over 500,000 Securities
Reuters · 07/08 22:27
FDA Approves Grand Pharmaceutical Group's Innovative SIR-Spheres Y-90 Resin Microsphere Injection Ahead of Schedule
Reuters · 07/07 13:04
Weekly Report: what happened at TLX last week (0630-0704)?
Weekly Report · 07/07 12:26
Telix Pharmaceuticals Trial Enter Critical Stage, Analyst Predicts Big Gains
Benzinga · 07/03 15:05
More
About TLX
Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its segments include Therapeutics, Precision Medicine and Telix Manufacturing Solutions. Therapeutics segment develops targeted radionuclide therapies for urologic, neurologic, musculoskeletal and hematological cancers. Precision Medicine segment focuses on bringing diagnostic imaging solutions to market. Precision Medicine segment also includes MedTech and International businesses. Telix Manufacturing Solutions segment is its global network of facilities designed to deliver patient doses worldwide. Its pipeline products include TLX591, TLX250, TLX101, TLX66, TLX592, TLX252, TLX400, Illuccix (68Ga-PSMA-11) and TLX007-CDx.

Webull offers Telix Pharmaceuticals Ltd stock information, including NASDAQ: TLX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TLX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TLX stock methods without spending real money on the virtual paper trading platform.